Airway Inflammation
18
2
2
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
50%
6 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (18)
Can Astaxanthin Help Manage Asthma in POlluted Areas?
Immune Status and Disease Control of Inflammatory Airway Diseases
Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity
To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility
Woodsmoke Particulate + Hypertonic Saline
An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients
Woodsmoke Particulate + Prednisone
Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)
A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults
The Value of FeNO in Predicting Airway Eosinophilic Inflammation
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma
Study of Biomarkers of Airway Inflammation (0000-128)
Children's Exposures/Health Effects/Diesel Exhaust
Lung Function and Airway Inflammation in Portland Cement Workers
HIPWOODS - Health Effects Related to Exposure to Particle Pollution From Woodburning Stoves
Effect of Aerobic Training on Asthmatic Patients
Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?